Reactions 1680, p319 - 2 Dec 2017 Thrombocytopenia and nausea: case report An 8-year-old boy developed thrombocytopenia and nausea during treatment with temozolomide [route and times to reactions onsets stated; not all outcomes stated]. The boy was diagnosed with an anaplastic oligodendroglioma in the frontal lobe with local leptomeningeal involvement and periventricular subcallosal extension, for which he underwent a near total resection and also had a 1p/19q codeletion. He was started on temozolomide 200 mg/m /day for five days every 28 days for a total of 12 cycles. He tolerated the temozolomide therapy well except for the development of thrombocytopenia and minor nausea. The boy’s temozolomide therapy was delayed once for thrombocytopenia, and his nausea was relieved using ondansetron. His tumour was an isocitrate dehydrogenase wild-type tumour, which showed MGMT gene promoter methylation and harboured a BRAF alteration, an ATRX mutation and CHEK1 frameshift mutation. Author comment: "Based on the favorable cytogenetics (but prior to the IDH sequencing, which was only available later), conservative management with [temozolomide] 200 mg/m daily for 5 days every 28 days for 12 cycles was employed. Therapy was well tolerated with one delay for thrombocytopenia and minor nausea relieved with ondansetron." Sorge C, et al. Complete durable response of a pediatric anaplastic oligodendroglioma to temozolomide alone: Case report and review of literature. Pediatric Blood and Cancer 64: e26708, No. 12, Dec 2017. Available from: URL: http://doi.org/10.1002/pbc.26708 - USA 803284351 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud